knowledge -WSS

knowledge

author：focus 2025-10-01 18:45:19 - browse：9835

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How I helped Pfizer think through the ethics of Viagra

focus

WSS

Change Healthcare can notify patients about the breach, HHS says

How to ethically and practically extend health care to all

CDC recommends RSV monoclonal antibody for infants

Cord blood banking comes at a high cost to babies

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Wikipedia

knowledge

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Woman returns to dialysis after doctors remove transplanted pig kidney

The cancer drug shortage isn’t new — and neither are the solutions

The Pandemic Treaty must support building strong health systems

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to increase colonoscopy rates? Looks like an AI can help

Tori Bowie and the unacceptable rates of Black maternal death

ASCO: AstraZeneca says CAR

Sports medicine is finally prioritizing gender equality

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

leisure time

Innovation in antibiotics is ailing. 'Brain drain' may kill it

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

FDA approves Sage Therapeutics’ rapid

It costs an awful lot of money to give away a kidney

BMI, flaws aside, is found to be useful estimate of body fat in youth

leisure time

focus

Wikipedia

focus